• In 2025, Ryan Specialty Holdings Inc. reported a 21.3% increase in total revenue to over US$3.05 billion, completed five acquisitions expected to add more than US$125 million in annualized revenue, and launched the three-year Empower Program restructuring to streamline operations and target annual savings of US$80 million by 2029.
• This combination of strong top-line expansion, acquisition-driven scale in its Underwriting Management specialty, and a multi-year cost-efficiency plan highlights management’s focus on building a larger, more efficient specialty insurance platform.
• Next, we’ll examine how the Empower restructuring program and its targeted cost savings could influence Ryan Specialty’s existing investment narrative.

The future of work is here. Discover the 28 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Ryan Specialty Holdings Investment Narrative Recap

To own Ryan Specialty Holdings, you need to believe it can turn its specialist distribution platform, acquisitions, and expense discipline into durable earnings, despite cyclical property pricing and higher operating costs. The 2025 results and the new Empower Program do not remove the near term risk that softer property pricing and rising expenses could pressure margins, but they do slightly strengthen the case that cost control can become a more visible short term support.

Among recent announcements, the launch of the Empower restructuring program is most relevant here. With management targeting US$80 million in annual savings by 2029, Empower directly addresses concerns about rising costs from investments in talent and new platforms. If executed well, these savings could help offset margin pressure if property pricing stays weak and give the company more room to absorb integration and technology spending tied to its growth initiatives.

Yet, despite these plans, investors still need to be aware that prolonged property pricing declines could...

Ryan Specialty Holdings’ narrative projects $4.5 billion revenue and $1.1 billion earnings by 2028. This requires 17.6% yearly revenue growth and about a $1.0 billion earnings increase from $57.8 million today.

Uncover how Ryan Specialty Holdings' forecasts yield a $54.88 fair value, a 38% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already projecting revenue near US$5.0 billion and earnings of about US$1.1 billion by 2028, which is a far more upbeat view than the consensus that highlights property pricing declines and rising costs as key threats. With the new Empower Program and 2025 results now in the mix, you can see how opinions on Ryan Specialty’s upside and downside could shift quite a bit from here.

Explore 4 other fair value estimates on Ryan Specialty Holdings - why the stock might be worth over 2x more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Ryan Specialty Holdings research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Ryan Specialty Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ryan Specialty Holdings' overall financial health at a glance.

Interested In Other Possibilities?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Capitalize on the AI infrastructure supercycle with our selection of the 35 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• We've uncovered the 16 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.